Prevalence of metabolic syndrome in patients with essential hypertension - Impact of gender;Rozpowszechnienie zespołu metabolicznego u chorych z nadciśnieniem tȩtniczym w zależności od płci

Nadcisnienie Tetnicze

Volumn 9, Issue 6, 2005, Pages 458-462

  Lakowska, Anna ^a   Chrostowska, Marzena ^a   Szyndler, Anna ^a   Śmiałek, Katarzyna ^a   Szczȩch, Radosław ^a   Zdrojewski, Tomasz ^a   Narkiewicz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Gender; Hypertension; Metabolic syndrome; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 32444450902     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005; 111: 1448-1454.
2. Lakka H.M., Laaksonen D.E., Lakka T.A. i wsp. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
3. Hu G., Qiao Q., Tuomilehto J. i wsp. Prevalence of metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch. Intern. Med. 2004; 164: 1066-1076.
4. National Cholesterol Education Program, Adult Treatment Panel III, 2001. JAMA 2001; 285: 2486-2497.
5. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
6. Zdrojewski T., Bandosz P., Szpakowski P. i wsp. Ocena wybranych problemów dotycza̧cych rozpowszechnienia i terapii nadciśnienia tȩtniczego w Polsce na podstawie badania NATPOL PLUS. W: Wiȩcek A., Kokot F. (red.). Postȩpy w nefrologii i nadciśnieniu tȩtniczym. Tom II. Medycyna Praktyczna, Kraków 2002: 10-15.
7. Schillaci G., Pirro M., Vaudo G., Mannarino M.R., Savarese G., Pucci G., Franklin S.S., Mannarino E. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 2005; 45: 1078-1082.
8. Scuteri A., Najjar S.S., Muller D.C., Andres R., Hougaku H., Metter E.J., Lakatta E.G. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J. Am. Coll. Cardiol. 2004; 43: 1388-1395.
9. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-3072.
10. Schillaci G., Pirro M., Vaudo G., Gemelli F., Marchesi S., Porcellati C., Mannarino E. Prognostic value of the metabolic syndrome in essential hypertension. J. Am. Coll. Cardiol. 2004; 43: 1817-1822.
11. Isomaa B., Almgren P., Tuomi T. i wsp. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
12. Anderson J.W., Konz E.C. Obesity and disease management: effects of weight loss on comorbid conditions. Obes. Res. 2001;9 (supl. 4): 326S-334S.
13. McGill H.C. Jr, McMahan C.A., Herderick E.E. i wsp. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002; 105: 2712-2718.
14. Grundy S.M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002; 105: 2696-2698.
15. Sharma A.M. Is there a rationale for angiotensin blockade in the management of obesity hypertension? Hypertension 2004; 44: 12-19.
16. Engeli S., Böhnke J., Gorzelniak K. i wsp. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-362.
17. Miettinen H., Lehto S., Salomaa V. i wsp. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care 1998; 21: 69-75.
18. Luźniak P., Czech A., Wojciechowska-Luźniak A., Tatoń J. Epidemiologia choroby niedokrwiennej serca u osób z cukrzyca̧ typu 2 w Polsce. Terapia 2004; 3: 7-10.
19. Norhammar A., Tenerz A., Nilsson G. i wsp. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus - a prospective study. Lancet 2002; 359: 2140-2144.
20. Kannel W.B. Risk stratification in hypertension: new insights from the Framingham Study. Am. J. Hypertens. 2000; 13 (1 cz. 2): 3S-10S.